Related Experiment Video
Updated: Jul 11, 2026
04:05
Endoscopic Vacuum Therapy for the Treatment of Anastomotic Leakage after Total Gastrectomy with Esophagojejunostomy
Published on: August 22, 2025
Evolving therapy for fecal incontinence
Jane J Y Tan1, Miranda Chan, Joe J Tjandra
1Department of Colorectal Surgery, Royal Melbourne Hospital, Melbourne, Australia. janetanjy@yahoo.com.sg
Diseases of the Colon and Rectum
|September 18, 2007
Summary
Surgical options for fecal incontinence are evolving. Injectable therapies and sacral nerve stimulation are becoming key treatments for moderate to severe cases, potentially avoiding stomas.
Area of Science:
- Gastroenterology
- Colorectal Surgery
- Pelvic Floor Disorders
Background:
- Fecal incontinence (FI) is a prevalent condition with significant psychosocial impact.
- Current nonoperative management includes dietary changes, medications, and biofeedback.
- Traditional surgical treatment, sphincteroplasty, is indicated for external sphincter defects.
Purpose of the Study:
- To review and evaluate the evidence for various surgical treatments for fecal incontinence.
- To analyze the current trends and future directions in surgical management of FI.
Main Methods:
- Literature review of surgical options for fecal incontinence.
- Critical evaluation of existing evidence for different procedures.
- Analysis of treatment algorithms and outcomes.
Main Results:
- The surgical landscape for fecal incontinence is shifting towards newer modalities.
- Injectable therapies show promise for moderate FI.
- Sacral nerve stimulation is a leading option for severe FI.
Conclusions:
- Sphincteroplasty remains relevant for a select group with isolated sphincter defects.
- Innovative treatments like injectable implants and sacral nerve stimulation are increasingly important.
- The goal is to improve outcomes and avoid colostomy in most patients.
Related Concept Videos
01:21Drugs for Treatment of Constipation-Predominant IBS
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
01:17Drugs for Treatment of Diarrhea-Predominant IBS
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
01:30Irritable Bowel Syndrome III: Medical and Nursing Management
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
01:21Inflammatory Bowel Disease V: Surgical Management
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
01:17Irritable Bowel Syndrome I: Introduction
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...